GLP-1 Endometriosis Treatment?: Why Some Women Say Their Pain Improved on Ozempic

Can GLP-1 medications like Ozempic actually help with endometriosis? In this episode, we explore the science behind inflammation, fibrosis, and metabolic dysfunction—and why these drugs may offer more than just weight loss benefits. 00:00 – Introduction & why this matters 01:10 – Do GLP-1s actually treat endometriosis? 02:10 – Endometriosis as a full-body inflammatory disease 03:45 – Altered GLP-1 signaling in endometriosis 05:00 – How GLP-1s may reduce inflammation 06:20 – Natural ways to lower inflammation 06:55 – GLP-1s, fibrosis, and scar tissue (adhesions) 08:10 – Practical strategies for scar tissue & pain 09:50 – Hormone resistance & inflammation connection 11:40 – Immune system, oxidative stress & brain fog 13:00 – Endo fatigue and mitochondrial dysfunction 14:20 – Why this is still experimental (no clinical trials) 16:30 – Cardiovascular risk in endometriosis 17:30 – Blood sugar, insulin resistance & GLP-1 benefits 19:10 – Who may benefit most from GLP-1s 20:20 – Which GLP-1 is best? (semaglutide vs tirzepatide) 22:00 – Why GLP-1s aren’t a cure 23:00 – Holistic approach to endometriosis management 24:00 – Final thoughts & next steps This Episode Is Brought to You By This episode is brought to you by The Endometriosis Reset, my step-by-step program designed to help women address the full-body drivers of endometriosis symptoms, including inflammation, blood sugar instability, endo belly, fatigue, scar tissue support, and nervous system dysregulation. Inside the program, I walk you through clear protocols for nutrition, supplement timing and dosing, lifestyle support, and the conversations to have with your doctor so you can stop piecing together conflicting advice online. Learn more at http://drbrighten.com/endocourse EndoGlobal Group At EndoGlobal Group, a network of world-class endometriosis specialists comes together to provide comprehensive, multidisciplinary care for patients with complex endometriosis—offering advanced diagnostic mapping, complete excision surgery, and holistic support. Click here to learn more and schedule a free consultation https://drbrighten.com/endoglobal 👩🏻‍⚕️Follow Dr. Jolene Brighten: 💻 Website: https://www.drbrighten.com 📸 Instagram:   / drjolenebrighten   🎥 TikTok:   / drjolenebrighten   🧵Threads: https://www.threads.net/@drjolenebrig... 🌟 Grab my free hormone friendly recipes here! https://drbrighten.com/hormonekit/ 🎧 Subscribe to the Podcast: Apple: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/5VWcYWJ... YouTube:    / @drjolenebrighten   👉 If you found this episode valuable, drop a comment below to tell us what you loved most, and share it with a friend! Let’s spread the knowledge. 💬✨ Dr. Jolene Brighten is a board-certified naturopathic endocrinologist, a Fellow of the American Board of Naturopathic Endocrinology (FABNE), a Menopause Society Certified Practitioner (MSCP), a nutrition scientist, and a certified sex counselor through the Sexual Health Alliance. As a licensed physician maintaining an active DEA license and full prescriptive authority, her educational frameworks align with leading global standards, including ESHRE and The Menopause Society. She serves as a faculty member for the American Academy of Anti-Aging Medicine (A4M), acts as the Lead Researcher for the Brighten Essentials Research Division, and is currently directing ongoing scientific research initiatives to advance clinical care standards for women navigating complex endocrinology, neurodivergence, and tissue-specific hormone sensitivities. Disclaimer: The views and opinions expressed in this podcast are solely my own and do not represent those of my employer or any affiliated organization. The discussion is intended for general educational purposes about women’s health and endometriosis care on a global level. References to challenges in diagnosis, access, or treatment reflect systemic issues in medicine as a whole and are not directed at any specific institution or provider. No patient information or organizational data are discussed.